Steger G G, Wrba F, Mader R, Schlappack O, Dittrich C, Rainer H
Department of Chemotherapy, University of Vienna, Austria.
Eur J Cancer. 1991;27(3):254-6. doi: 10.1016/0277-5379(91)90509-c.
Clear cell sarcoma of tendons and aponeuroses is a rare disorder which originates from migrated neural crest cells. It tends to local recurrences and dissemination and the prognosis has to be considered as poor. Based on a small series of patients, a wide surgical excision of the primary tumour or amputation are the therapies of choice. Radiotherapy might be of some value as an adjuvant treatment but radiotherapy and chemotherapy are of little value in the treatment of the advanced disease. Because of the lack of treatment alternatives we treated a 40-year-old female patient with disseminated clear cell sarcoma with interferon-alpha 2b (IFN-alpha 2b) perilesionally after several courses of systemic chemotherapy and radiotherapy had failed. After 4 months of therapy the patient came into a complete pathological remission which lasted for 17 months. A relapse of round cell sarcoma on both tumour sites was then noted. This outcome shows that IFN-alpha 2b was able to induce a complete remission in clear cell sarcoma and might have altered the natural course of the disease. IFN-alpha should be studied as adjuvant therapy after surgery of primary clear cell sarcoma and as a first-line palliative treatment in disseminated disease.
腱膜透明细胞肉瘤是一种罕见的疾病,起源于迁移的神经嵴细胞。它易于局部复发和扩散,预后较差。基于一小部分患者,广泛切除原发性肿瘤或截肢是首选的治疗方法。放疗作为辅助治疗可能有一定价值,但放疗和化疗在晚期疾病的治疗中价值不大。由于缺乏其他治疗选择,我们对一名40岁患有播散性透明细胞肉瘤的女性患者在几个疗程的全身化疗和放疗失败后,在肿瘤周围注射α-2b干扰素(IFN-α 2b)进行治疗。经过4个月的治疗,患者达到完全病理缓解,持续了17个月。随后在两个肿瘤部位均发现圆形细胞肉瘤复发。这一结果表明,IFN-α 2b能够诱导透明细胞肉瘤完全缓解,并可能改变了疾病的自然进程。IFN-α应作为原发性透明细胞肉瘤手术后的辅助治疗以及播散性疾病的一线姑息治疗进行研究。